Date

2007

Deeks, A, Zoungas, S, Teede H. Risk Perception in Women: a focus on Menopause. (In press Menopause accepted 5/2007).
 
Peverill RE, Teede HJ, Malan E, Kotsopoulos D, Smolich JS, McGrath BP. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. (In press accepted 3/2007 Clin Exp Physiol Pharmacol) 

Teede, H, Stuckey B.  PCOS and abnormal glucose tolerance. (In press Med J Australia, 2007) 

Teede HJ, Zoungas S, Hutchison S. Improving insulin sensitivity in PCOS. (In press, invited review, Trends in Endocrinology and Metabolism 2007)

Meyer C, McGrath BP, Teede HJ. The effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007, 30(3); 471-478. 

Teede, HJ. Sex steroids: Effects on the cardiovascular system. Clin Exp Physiol, Pharmacol 2007, 34: 672-676

2006

Zoungas S, Teede HJ. Does Metformin Treatment Really Improve Arterial Structure in Women with Polycystic Ovarian Syndrome. (Letter) J Clin Endo Metab online Oct 2006.

Liang YL, Teede HJ, Dalais F, McGrath B. The effects of phytoestrogen on blood pressure and lipids in healthy volunteers. Chinese Medical Journal 2006 ;34(8):726-9.

Grossmann M, Fuller P, Hunter A, Teede H. Isolated ACTH deficiency presenting as severe hypercalcaemia. Clin Endocrinol, 2006 (In press, accepted Oct 2006)

Teede, HJ. Sex steroids: Effects on the cardiovascular system. Clin Exp Physiol, Pharmacol (In press, accepted Nov 2006).

Teede HJ, Kotsopoulos D, Dalais FS, Hodgson, J, McGrath BP. Dietary soy supplementation does not affect blood pressure or arterial function in hypertensive subjects: A randomised placebo-controlled study in men and postmenopausal women. (In press, J Am Coll J Clin Nutrition, accepted November 2006).

Meyer C, McGrath BP, Teede HJ. The effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. (In press Diab Care, accepted Dec 2006)

Teede HJ, Zoungas S, Hutchison S. Improving insulin sensitivity in PCOS. (In press, invited review, Trends in Endocrinology and Metabolism 2007)

Teede HJ, Norman R. Polycystic ovarian syndrome: insights into the enigma that is PCOS today Endocrine, 2006 ; 30(1):1-2

Teede HJ. Polycystic ovarian syndrome - Update. Diabetes Management Journal 2006, 16: 54-63.

Teede HJ, Zoungas S, Hutchison S, Meyer C. Insulin resistance, Metabolic syndrome, diabetes and Cardiovascular disease in Polycystic Ovarian Syndrome.Endocrine 2006 ; 30(1):45-53

Liang YL, Teede HJ, Dalais F, McGrath B. The effects of phytoestrogen on blood pressure and lipids in healthy volunteers. Chinese Medical Journal 2006 ; 34(8):726-9.

Zoungas S, Teede HJ. Does Metformin Treatment Really Improve Arterial Structure in Women with Polycystic Ovarian Syndrome. (Letter) J Clin Endo Metab. 2006.

Hutchison S, Zoungas S, TeedeHJ. Insulin resistance in PCOS. (Letter) MJA

2005

Burger HG, Teede H.  Endocrine changes during the Perimenopause.  Treatment of the Postmenopausal Woman:  Basic and Clinical Aspects.  Lobo RA (ed).  Third Edition.  LippincottWilliams & Wilkins (editors).  Philadelphia.  2005

Burger HG, Robertson DM, Baksheev L, Collins A, Csemiczky G, Landgren BM. The relationship between the endocrine characteristics and the regularity of menstrual cycles in the approach to menopause. Menopause. 2005 May-Jun;12(3):267-74

Teede H, Dalais FS, Kotsopoulos D, McGrath BP, Malan E, Gan TE, Peverill R. Dietary Soy Containing Phytoestrogens Does Not Activate the Hemostatic System in Postmenopausal Women.  Journal of Clinical Endocrinology and Metabolism.  2005 April; 90(4):1936-41.

Meyer C, Talbot M, Teede HJ. Effect of Implanon on insulin resistance in women with Polycystic Ovary Syndrome.  Australian & New Zealand Journal of Obstetrics & Gynaecology.  2005 April; 45(2):155-8.

Meyer C, McGrath BP, Cameron JD, Kotsopoulos D, Teede HJ. Vascular Dysfunction and Metabolic Parameters in Polycystic Ovary Syndrome.  Journal of Clinical Endocrinology and Metabolism.  2005 August; 90(8):4630-5.

Meyer C, McGrath BP, Teede HJ. Overweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease.  Journal of Clinical Endocrinology and Metabolism.  2005 October; 90(10):5711-6.

Teede HJ, Meyer C, Norman R. Insulin sensitiers in the treatment of PCOS.  Expert Opinion in Pharmacotherapy.  2005 November; 6(14):2419-27.

Zoungas S, Teede HJ. Does Metformin treatment really improve arterial structure in women with Polycystic Ovarian Syndrome?  Journal of Clinical Endocrinology and Metabolism.  eLetter.  2005 November 30.

Teede HJ. Hormone Therapy Update. Polish Medical Journal.  2005; 7:800-805.

Burger HG, Teede H.  Endocrine changes during the Perimenopause.  Treatment of the Postmenopausal Woman:  Basic and Clinical Aspects.  Lobo RA (ed).  Third Edition.  LippincottWilliams & Wilkins (editors).  Philadelphia.  2005

2004

Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric. 2004 Dec;7(4):375-89.

Teede HJ. Hormone therapy--weighing up the evidence. Aust Fam Physician. 2004 Nov;33(11):875-80.

Teede HJ, Reddish S, Deeks AA, Farrell E, Murkies A. Menopause forum--a case discussion on midlife issues. Aust Fam Physician. 2004 Nov;33(11):903-5.

Reddish S. Menopause--a treatment algorithm. Aust Fam Physician. 2004 Nov;33(11):900-1.

Reddish S. Assessment of women in midlife. Aust Fam Physician. 2004 Nov;33(11):883-7.

Deeks AA. Is this menopause? Women in midlife--psychosocial issues. Aust Fam Physician. 2004 Nov;33(11):889-93.

Murkies A. If not hormones--then what? Aust Fam Physician. 2004 Nov;33(11):895-9.

Farrell E. Dysfunctional uterine bleeding. Aust Fam Physician. 2004 Nov;33(11):906-8.

McHorney,CA Rust J, Golombok S, Davis SR, Bouchard C, Brown C, Basson R, Donati Sarti C, Kuznicki J, Derogatis L. The Profile of Female Sexual Function (PFSF)Ó: A Patient-Based, International, Psychometric Instrument for the Assessment of Hypoactive Sexual Desire in Oophorectomized Women Menopause ( in press).

Jackson, B.D, Teichtahl, A.J., Morris, M.E., Wluka, A.E., Davis, S.R., Cicuttini, F.M.. The effect of the knee adduction moment on tibiofemoral cartilage volume and bone size in healthy women. Rheumatology 2004 Mar;43(3):311-4.

Somboonporn W, Davis SR. Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women . Endocrine Reviews 2004 25(3):374-388.

Wluka, A.E., Wolfe, R., Davis, S.R., Stuckey, S., Cicuttini, F.M. Tibial cartilage volume change in healthy postmenopausal women: a longitudinal study. Ann Rheum Dis ; 63:444-449

Rivera-Woll LM, Davis SR. Postmenopausal hormone therapy – the pros and cons. Int Med J 2004 Mar; 34(3):109-14.

Davis SR, O’Neill, Eden J, Baber R, Ekangaki A Stocks JM, Thiebaud D. Transition to raloxifene with and without low dose estrogen therapy: effects on the endometrium and patient satisfaction. Menopause 2004 Mar-Apr;11(2):167-75

Flavia Cicuttini, Anita Wluka, Susan Davis, Boyd Strauss Stella Yeung Peter Ebeling. Association between knee cartilage volume and bone mineral density in older adults without osteoarthritis. Rheumatology

Rivera-Woll LM, Papalia, M-A, Davis SR, Burger HG. Clinical impact of androgen insufficiency in women . Update in Human Reproduction accepted March 04

Misso ML, Jang C, Adams J, Tran J, Murata Y, Bell R, Chin Boon W, Simpson ER, Davis SR. Adipose aromatase gene expression increases following menopause and is unaffected by postmenopausal estrogen therapy. Menopause (Accepted April 2004)

Somboonporn W, Davis SR. Postmenopausal Testosterone Therapy and Breast Cancer Risk. Maturitas (Accepted 2004)

Davis, SR. The use of testosterone after menopause. J Br Menopause Soc (Accepted 2003)

Davis SR, Guay AT, Shifren JL, Mazer NA. Endocrine Aspects of Female Sexual Dysfunction. In: 2nd International Consultation on Erectile and Sexual Dysfunction. Eds T Lue, S Khoury (in press)

2003

Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M,  Clyne CD, Davis SR, Simpson ER, Carani C. Dysmetabolic Syndrome in a man with a novel mutation of the aromatase gene: effects of Testosterone, Alendronate and Estradiol treatment. Clin Endo Metab 2004( in press)

Davison SL, Davis SR.  Androgens in women. J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):363-6.

Cicuttini FM, Wluka AE, Wang Y, Stuckey SL, Davis SR. Effect of estrogen replacement therapy on patella cartilage in healthy women. Clinical and Experimental Rheumatology, Clin Exp Rheumatol. 2003 Jan-Feb;21(1):79-82.

Davison S, Davis SR. Hormone replacement therapies: current controversies. Clin Endocrinol 2003; 58(3): 249-261.

Davis SR, Simpson ER. Tibolone was associated with an increase in 7 alpha-methyl-ethinylestradiol. Menopause. 2003 Jan-Feb;10(1):105-6; author reply 106-7.

Davis SR, Burger HG. The role of androgen therapy. Best Pract Res Clin Endocrinol Metab. 2003 17;1:165-175.

Davis SR Knight S, Davis BJ, Bell R. Climacteric symptoms among indigenous Australian women and a model for the use of culturally relevant art in health promotion. 2003 Menopause 10;4:345-351.

Davis SR, Bradbury J, Bell R, Johns JA. Acute administration of conjugated equine estrogen does not improve exercise induced myocardial ischaemia in men with coronary artery disease. Intern Med J. 2003 May;33(5-6):221-4.

Papalia M-A, Davis SR What is the rationale for androgen therapy for women. Treatments in Endocrinology 2003 2:(2)77-84.

Davis SR. Menopause: New Therapies.2003 Med J Aust 2003 178: 634-637.

Goldstat R, Briganti E, Tran J, Wolf R, Davis SR. Transdermal testosterone improves well being, mood and sexual function in premenopausal women. Menopause 2003 10(5):390-398.

Davison, S, Davis SR New markers for cardiovascular disease risk in women –impact of endogenous estrogen status and exogenous estrogen treatment. J Clin Endocrinol Metab 2003 88 (6) 2470-2478 .

Teichtahl A, Jackson B, Morris M, Wluka A, Baker R, Davis SR, Cicuttini F. The relationship between knee flexion during walking and patella carlilage and bone volume in healthy women. 2004 Rheumatology (in press) .

Davis SR Knight S, Davis BJ, Bell R Aminina Nud Mulumuluna (You gotta look after yourself) An evaluation of the use of traditional art in health promotion for Aboriginal people in the Kimberley regions of Western Australia. Australian Psycologist 2004 (in press).

Davis SR, O’Neill, Eden J, Baber R, Ekangaki A Stocks JM, Thiebaud D. Transition to raloxifene with and without low dose estrogen therapy: effects on the endometrium and patient satisfaction. Menopause 2004 (in press).

O'Neill SM, Eden J, Baber R, Ekangaki A, Stocks JM, Wolthers T, Davis SR. Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogen - a pilot study. Climacteric. 2003 Dec;6(4):347-53.

2002

Cicuttini,FM, Wluka AE, Wang Y, Davis SR, Hankin J, Ebeling P. Compartment differences in knee cartilage volume in healthy adults. J Rheumatol 2002; 29 (3) 554-556.

Davis SR, Goldstat R, Newman A, Berry, K, Burger HG, Meredith I, Koch K. Differing effects of low dose estrogen and progestin replacement therapy and pravastatin in hypercholesterolemic postmenopausal women. Climacteric 2002; 5:341-350.

Britt KL, Kerr J, O’Donnell L, Jones ME, Drummond AE, Davis SR, Simpson ER, Findlay JK. Oestrogen regulates development of the somatic cell phenotype in the eutherian ovary FASEB 2002 16(11):1389-97.

Davis SR. How to treat: management of menopause after breast cancer. Australian Doctor March 2002.

Bachmann, G Bancroft, J, Braunstein, G, Burger, H Davis SR, Dennerstein, L, Goldstein,I, Guay, A, Leiblum, S, Lobo, R, Notelovitz, M., Rosen, R, Sarrel P, Sherwin, B, Simon, J, Simpson, ER, Shifren, J, Spark, RM.D, Traish, A. Female Androgen Insufficiency: The Princeton Consensus Statement On Definition, Classification And Assessment. Fertility Sterility 2002; 77(4): 660-665 .

Davis SR. Effects of tibolone on mood and libido Menopause 2002; 9(3):162-170.

Davis SR. Postmenopausal hormone replacement therapy. N Eng J Med 2002;346(1):63-5 (LETTER).

Burger HGB, Davis SR. The role of androgen therapy. Best Pract Res Clin Obstet Gynaecol. 2002 Jun;16(3):383-93. (Review)

Davis SR. When to suspect androgen deficiency other than at menopause Fertility Sterility 2002; 77(4)S4:68-71.

Leventhal Alexander J, Kotz K, Davis S. Estrogen and Androgen: Mood, Sexual Function, and Quality of Life in the Menopausal Woman. In: Lobo RA, Crosignani PG, Paoletti R, Bruschi F, editors. Women's Health and Menopause: New Strategies - Improved Quality of Life. Kluwer Academic Publishers: Dordrecht, The Netherlands, 2002 (in press).

Guay, A, Davis SR. Testosterone insufficiency in women: fact or fiction? World Journal of Urology 2002;20(2):106-10.

Bass SL, Bennell KL, Cameron ID, Davis SR, et al. Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Med J Aust 2002 176: S1-S16.

Davis SR, Knight S, White, V, Claridge C., Davis BJ, Bell R. Indication of a high prevalence of polycystic ovarian syndrome in Australian Indigenous women. Gynecol Endocronol 2002;16 443-446.

Burger HG, Davis SR. The Role of Androgen Therapy in Bailliere's Best Practice in Research Clinical Obstetrics & Gynaecologist. 2002;16(3) 383-93.

Davis SR, Burger HG. Risks of postmenopausal hormone replacement JAMA. 2002 Dec 11;288(22):2820. (Letter)

2001

Wluka AE, Davis SR, White V, Bailey M, Stuckey SL, Cicuttini FM. Users of Oestrogen Replacement Therapy have more knee cartilage than Non-users. Annals Rheumatol Dis 2001;60(4):332-6..

Jang,C, Bell R, White V, Dwyer K, Kerr PG, Davis SR. Women's health issues in haemodialysis patients: are they being addressed. MJA 2001,175:298-301.

Teede H, McGrath B, Liang YL, Davis SR, Kotsopulous Dalais F. Dietary Soy has both beneficial and potentially adverse effects on the human cardiovascular system: A placebo controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001:86:3053-3060.

Davis SR, Briganti E, Chen R, Dalais F, Bailey M, Burger HG. The role of specific Chinese medicine in the management of postmenopausal vasomotor symptoms in Caucasian women - a randomised controlled study. MJA 2001; 174(2):68-71. [ WITH EDITORIAL]

Worboys S, Kotsopoulos D, Teede H, McGrath B, Davis SR. Parental testosterone improves Endothelium-Dependent and Independent Vasodilation in Postmenopausal women already receiving estrogen. J Clin Endocrinol Metab 2001 86(1) 158-161.

Simpson ER, Davis SR. Mini Review-Aromatase and the regulation of estrogen biosynthesis-some new perspectives Endocrinology 2001;142(11): 4589-94.

Davis SR. Is phytoestrogen therapy a viable option for the management of menopausal symptoms? BMJ 2001,323:354-5. (Invited editorial)

Tran J, Davis SR. Hirsutism, management and therapeutic options. New Ethicals Journal. 2001; October: 65-71.

Davis SR. Testosterone Deficiency in women. J Reproductive Medicine 2001;46 (3);291-296.

Davis SR. Testosterone treatment: Psychological and physical effects in postmenopausal women. Menopausal medicine Vol 9(2) Summer 2001.

Tran J, Davis SR. Exploring the management and therapeutic options of hirsutism. Current therapeutics 2001 April; 42(4)57-61.

Davis SR. Are phytoestrogens safe for breast cancer? Medicine Today Feb 2001: 109.

Davis SR. An external perspective on the report of the International Consensus Development Conference on Female Sexual Dysfunction: More work to be done. J Sex Marital Therapy 2001; 27(2):131-133.

Davis SR, Tran J. What are "normal" testosterone levels in women? J Clin Endocrinol Metab 2001; 86(4): 1842-1843. (letter)

Davis SR, Tran J. Testosterone influences libido and wellbeing. Trends in Endocrinology and Metabolism 2001;12(1):33-37.

2000

Murkies AL, Teede HJ, Davis SR. What is the role of phytoestrogens in treating menopausal symptoms? Med J Aust 2000;173: Supp S97-98.

Davis SR. Identifying and promoting the specific nutrition and physical activity needs of women aged 40 and over. Summary. Med J Aust 2000;173: Supp 109.

Davis SR. Why do women aged 40 and over need a different diet? What are their specific requirements are these met? Med J Aust 2000;173: Supp S95-96.

Murkies A, Dalais F, Briganti E, Burger HG, Healy DL, Wahlqvist M, Davis SR. Phytoestrogen and breast cancer in postmenopausal women: a case control study. Menopause 2000 7(5): 289-296.

Davis SR, Walker KZ, Strauss, BJG. Effects of estradiol with and without testosterone on body composition and relationships with lipids in post-menopausal women. Menopause 2000;7(6):395-401.

Simpson ER, Rubin G, Clyne C, Roberston K, O'Donnell L, Jones M, Davis SR. The Role of Local Estrogen Biosynthesis in Males and Females. Trends in Endocrinology Metabolism 2000 11(5)184-188.

Simpson ER, Davis SR. Another role highlighted for estrogens in the male sexual behaviour. Proc Natl Acad Sci USA 2000;97(26):14038-40.

Davis SR. Hormones and Sexual Desire The Journal of Sex Education and Therapy. 2000; 25(1):25-32. 

Davis SR. How to treat: Using androgens in women. The Australian Doctor Oct 2000.

Content updated October 04, 2007